ROIV insider transactions

SEC Form 4 filed by Roivant Sciences Ltd.

SEC Form 4 filed by Roivant Sciences Ltd.

CEO Gline Matthew covered exercise/tax liability with 76,171 shares, decreasing direct ownership by 0.46% to 16,583,774 units (SEC Form 4) to satisfy withholding tax

President and Vant Chair Torti Frank increased direct ownership by 0.30% to 13,495,893 units (SEC Form 4) to satisfy withholding obligation

President & CIO Sukhatme Mayukh covered exercise/tax liability with 46,879 shares, decreasing direct ownership by 0.25% to 18,583,860 units (SEC Form 4) to satisfy withholding tax

President & Immunovant CEO Venker Eric sold $7,324,000 worth of shares (200,000 units at $36.62) as part of a pre-agreed trading plan and exercised 200,000 shares at a strike of $3.85 (SEC Form 4)

Chief Accounting Officer Humes Jennifer covered exercise/tax liability with 3,880 shares, decreasing direct ownership by 4% to 106,419 units (SEC Form 4) (for tax liability)

CFO Pulik Richard covered exercise/tax liability with 2,129 shares, decreasing direct ownership by 0.78% to 269,681 units (SEC Form 4) (withholding tax)

Director Manchester Keith S was granted 5,054 shares, increasing direct ownership by 0.29% to 1,753,457 units (SEC Form 4)

Director Gold Daniel Allen was granted 5,054 shares, increasing direct ownership by 0.06% to 8,965,815 units (SEC Form 4)

Director Oren Ilan was granted 5,054 shares, increasing direct ownership by 4% to 123,680 units (SEC Form 4)

Director Momtazee James C was granted 5,054 shares, increasing direct ownership by 5% to 111,959 units (SEC Form 4)

Director Fitzgerald Meghan was granted 5,054 shares, increasing direct ownership by 14% to 41,162 units (SEC Form 4)

Director Epperly Melissa B, was granted 5,054 shares, increasing direct ownership by 51% to 14,954 units (SEC Form 4)

Director Epperly Melissa B, sold $196,230 worth of shares (4,938 units at $39.74) as part of a pre-agreed trading plan, decreasing direct ownership by 33% to 9,900 units (SEC Form 4)

Director Fitzgerald Meghan sold $203,152 worth of shares (5,112 units at $39.74) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 36,108 units (SEC Form 4)

Director Gold Daniel Allen covered exercise/tax liability with 5,133 shares, decreasing direct ownership by 0.06% to 8,960,761 units (SEC Form 4) (withholding tax)

Director Oren Ilan covered exercise/tax liability with 2,378 shares, decreasing direct ownership by 2% to 118,626 units (SEC Form 4) (withholding tax)

Director Epperly Melissa B, covered exercise/tax liability with 2,179 shares, decreasing direct ownership by 13% to 14,838 units (SEC Form 4) to satisfy withholding obligation

Director Fitzgerald Meghan covered exercise/tax liability with 1,743 shares, decreasing direct ownership by 4% to 41,220 units (SEC Form 4) to satisfy tax liability

Director Momtazee James C covered exercise/tax liability with 2,905 shares, decreasing direct ownership by 3% to 106,905 units (SEC Form 4) (for tax liability)

Director Fitzgerald Meghan exercised 20,000 shares at a strike of $8.80 and sold $798,000 worth of shares (20,000 units at $39.90) as part of a pre-agreed trading plan (SEC Form 4)

President & Immunovant CEO Venker Eric sold $7,153,393 worth of shares (200,000 units at $35.77) as part of a pre-agreed trading plan and exercised 200,000 shares at a strike of $3.85 (SEC Form 4)

CFO Pulik Richard covered exercise/tax liability with 5,749 shares, decreasing direct ownership by 2% to 271,810 units (SEC Form 4) (withholding obligation)

President & Immunovant CEO Venker Eric covered exercise/tax liability with 13,909 shares, decreasing direct ownership by 0.86% to 1,599,154 units (SEC Form 4) to cover withholding tax

President & CIO Sukhatme Mayukh sold $12,360,813 worth of shares (335,174 units at $36.88) and exercised 335,174 shares at a strike of $3.85 (SEC Form 4)

President & CIO Sukhatme Mayukh exercised 664,826 shares at a strike of $3.85 and sold $24,160,402 worth of shares (664,826 units at $36.34) (SEC Form 4)

President & Immunovant CEO Venker Eric exercised 200,000 shares at a strike of $3.85 and sold $6,990,000 worth of shares (200,000 units at $34.95) (SEC Form 4)

Director Epperly Melissa B, was granted 543 shares, increasing direct ownership by 3% to 17,017 units (SEC Form 4)

Director Oren Ilan was granted 775 shares, increasing direct ownership by 0.64% to 121,004 units (SEC Form 4)

Director Momtazee James C was granted 405 shares, increasing direct ownership by 0.37% to 109,810 units (SEC Form 4)

CEO Gline Matthew covered exercise/tax liability with 76,171 shares, decreasing direct ownership by 0.46% to 16,659,945 units (SEC Form 4) (for withholding tax)

Director Fitzgerald Meghan exercised 10,000 shares at a strike of $8.80 and sold $349,000 worth of shares (10,000 units at $34.90) (SEC Form 4)

President and Vant Chair Torti Frank covered exercise/tax liability with 40,310 shares, decreasing direct ownership by 0.30% to 13,536,202 units (SEC Form 4) to cover withholding tax

President & CIO Sukhatme Mayukh covered exercise/tax liability with 46,878 shares, decreasing direct ownership by 0.25% to 18,630,739 units (SEC Form 4) to satisfy tax liability

Director Epperly Melissa B, sold $610,252 worth of shares (17,750 units at $34.38) and exercised 17,750 shares at a strike of $4.46 (SEC Form 4)

Director Manchester Keith S sold $56,444,076 worth of shares (1,638,163 units at $34.46), decreasing direct ownership by 10% to 1,748,403 units (SEC Form 4)

Director Gold Daniel Allen sold $49,354,076 worth of shares (1,438,163 units at $34.32) (SEC Form 4)

Director by Deputization Qvt Financial Lp sold $49,354,076 worth of shares (1,438,163 units at $34.32) (SEC Form 4)

President & CIO Sukhatme Mayukh exercised 1,000,000 shares at a strike of $3.85 and sold $34,105,000 worth of shares (1,000,000 units at $34.10) (SEC Form 4)

President & Immunovant CEO Venker Eric exercised 200,000 shares at a strike of $3.85 and sold $6,631,268 worth of shares (200,000 units at $33.16) (SEC Form 4)

CFO Pulik Richard covered exercise/tax liability with 2,129 shares, decreasing direct ownership by 0.76% to 276,420 units (SEC Form 4) to satisfy tax liability

Chief Accounting Officer Humes Jennifer covered exercise/tax liability with 3,582 shares, decreasing direct ownership by 3% to 109,782 units (SEC Form 4) (for withholding tax)

President & Immunovant CEO Venker Eric exercised 200,000 shares at a strike of $3.85, sold $6,054,000 worth of shares (200,000 units at $30.27) and covered exercise/tax liability with 34,483 shares, decreasing direct ownership by 2% to 1,613,063 units (SEC Form 4) (withholding obligation)

CFO Pulik Richard covered exercise/tax liability with 18,962 shares, decreasing direct ownership by 6% to 278,549 units (SEC Form 4) to satisfy withholding tax

SEC Form 4 filed by Venker Eric

SEC Form 4 filed by Pulik Richard

SEC Form 4 filed by Humes Jennifer

SEC Form 4 filed by Oren Ilan

SEC Form 4 filed by Epperly Melissa B,

SEC Form 4 filed by Momtazee James C

SEC Form 4 filed by Gline Matthew

SEC Form 4 filed by Humes Jennifer

SEC Form 4 filed by Torti Frank

SEC Form 4 filed by Gline Matthew

SEC Form 4 filed by Sukhatme Mayukh

SEC Form 4 filed by Fitzgerald Meghan

SEC Form 4 filed by Pulik Richard

SEC Form 4 filed by Humes Jennifer

SEC Form 4 filed by Venker Eric